{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T13:17:02Z","timestamp":1791206222432,"version":"4.1.0"},"reference-count":23,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2012,12,1]],"date-time":"2012-12-01T00:00:00Z","timestamp":1354320000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Immunology"],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1016\/j.clim.2012.09.007","type":"journal-article","created":{"date-parts":[[2012,9,28]],"date-time":"2012-09-28T21:34:56Z","timestamp":1348868096000},"page":"241-250","source":"Crossref","is-referenced-by-count":31,"title":["Autoantibody stabilization of the classical pathway C3 convertase leading to C3 deficiency and Neisserial sepsis: C4 nephritic factor revisited"],"prefix":"10.1016","volume":"145","author":[{"given":"Elizabeth C.","family":"Miller","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole M.","family":"Chase","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Densen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary K.","family":"Hintermeyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James T.","family":"Casper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John P.","family":"Atkinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clim.2012.09.007_bb0005","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1056\/NEJM200104053441406","article-title":"Complement. First of two parts","volume":"344","author":"Walport","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.clim.2012.09.007_bb0010","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1056\/NEJM200104123441506","article-title":"Complement. Second of two parts","volume":"344","author":"Walport","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.clim.2012.09.007_bb0015","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/nri2231","article-title":"Complement driven by conformational changes","volume":"8","author":"Gros","year":"2008","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.clim.2012.09.007_bb0020","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1038\/nature04005","article-title":"Structures of complement component C3 provide insights into the function and evolution of immunity","volume":"437","author":"Janssen","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.clim.2012.09.007_bb0025","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1111\/j.1365-3083.2006.01729.x","article-title":"Clinical aspects and molecular basis of primary deficiencies of complement component C3 and its regulatory proteins factor I and factor H","volume":"63","author":"Reis","year":"2006","journal-title":"Scand. J. Immunol."},{"key":"10.1016\/j.clim.2012.09.007_bb0030","doi-asserted-by":"crossref","first-page":"2774","DOI":"10.1016\/j.molimm.2009.04.029","article-title":"Complement in human diseases: lessons from complement deficiencies","volume":"46","author":"Botto","year":"2009","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.clim.2012.09.007_bb0035","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/BF02918259","article-title":"Complement deficiency states and meningococcal disease","volume":"12","author":"Figueroa","year":"1993","journal-title":"Immunol. Res."},{"key":"10.1016\/j.clim.2012.09.007_bb0040","first-page":"82","article-title":"C3 nephritic factor and C4 nephritic factor in the serum of two patients with hypocomplementaemic membranoproliferative glomerulonephritis","volume":"76","author":"Tanuma","year":"1989","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.clim.2012.09.007_bb0045","first-page":"417","article-title":"Stabilization of the classical pathway C3 convertase C42, by a factor F-42, isolated from serum of patients with systemic lupus erythematosus","volume":"40","author":"Daha","year":"1980","journal-title":"Immunology"},{"key":"10.1016\/j.clim.2012.09.007_bb0050","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1111\/j.1365-2249.1994.tb06530.x","article-title":"Occurrence of C3 nephritic factor and C4 nephritic factor in membranoproliferative glomerulonephritis (MPGN)","volume":"95","author":"Ohi","year":"1994","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.clim.2012.09.007_bb0055","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1084\/jem.160.5.1558","article-title":"Inhibition of complement activation on the surface of cells after incorporation of decay-accelerating factor (DAF) into their membranes","volume":"160","author":"Medof","year":"1984","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.clim.2012.09.007_bb0060","doi-asserted-by":"crossref","first-page":"31160","DOI":"10.1074\/jbc.274.44.31160","article-title":"Decay accelerating activity of complement receptor type 1 (CD35). Two active sites are required for dissociating C5 convertases","volume":"274","author":"Krych-Goldberg","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.clim.2012.09.007_bb0065","doi-asserted-by":"crossref","first-page":"4948","DOI":"10.1182\/blood-2008-01-133702","article-title":"Mutations in complement C3 predispose to development of atypical hemolytic uremic syndrome","volume":"112","author":"Fremeaux-Bacchi","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.clim.2012.09.007_bb0070","doi-asserted-by":"crossref","first-page":"3150","DOI":"10.4049\/jimmunol.0901366","article-title":"Smallpox inhibitor of complement enzymes (SPICE): dissecting functional sites and abrogating activity","volume":"183","author":"Liszewski","year":"2009","journal-title":"J. Immunol."},{"key":"10.1016\/j.clim.2012.09.007_bb0075","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1055\/s-0030-1262885","article-title":"Anti-factor H autoantibody-associated hemolytic uremic syndrome: review of literature of the autoimmune form of HUS","volume":"36","author":"Dragon-Durey","year":"2010","journal-title":"Semin. Thromb. Hemost."},{"key":"10.1016\/j.clim.2012.09.007_bb0080","doi-asserted-by":"crossref","first-page":"18552","DOI":"10.1074\/jbc.M611650200","article-title":"Structure-based mapping of DAF active site residues that accelerate the decay of C3 convertases","volume":"282","author":"Kuttner-Kondo","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.clim.2012.09.007_bb0085","doi-asserted-by":"crossref","first-page":"812","DOI":"10.4049\/jimmunol.119.3.812","article-title":"The incorporation of C3 nephritic factor (C3NeF) into a stabilized C3 convertase, C3b, Bb (C3NeF), and its release after decay of convertase function","volume":"119","author":"Daha","year":"1977","journal-title":"J. Immunol."},{"key":"10.1016\/j.clim.2012.09.007_bb0090","first-page":"12","article-title":"The immunoglobulin nature of nephritic factor","volume":"32","author":"Scott","year":"1978","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.clim.2012.09.007_bb0095","first-page":"609","article-title":"C3 nephritic factor and SLE: report of four cases and review of the literature","volume":"87","author":"Walport","year":"1994","journal-title":"QJM"},{"key":"10.1016\/j.clim.2012.09.007_bb0100","doi-asserted-by":"crossref","DOI":"10.1038\/ki.2012.250","article-title":"Sensitive and specific assays for C3 nephritic factors clarify mechanisms underlying complement dysregulation","author":"Paixao-Cavalcante","year":"2012","journal-title":"Kidney Int."},{"key":"10.1016\/j.clim.2012.09.007_bb0105","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1172\/JCI109787","article-title":"Nephritic factor of the classical pathway of complement. Immunoglobulin G autoantibody directed against the classical pathway C3 convertase enzyme","volume":"65","author":"Halbwachs","year":"1980","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.clim.2012.09.007_bb0110","doi-asserted-by":"crossref","first-page":"38476","DOI":"10.1074\/jbc.M307017200","article-title":"Formation of high-affinity C5 convertase of the classical pathway of complement","volume":"278","author":"Rawal","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.clim.2012.09.007_bb9000","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/0090-1229(88)90009-8","article-title":"Epstein-Barr virus transformed B cell lines derived from patients with systemic lupus erythematosus produce a nephritic factor of the classical complement pathway","volume":"46","author":"Hiramatsu","year":"1988","journal-title":"Clin. Immunol. Immunopathol."}],"container-title":["Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S152166161200232X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S152166161200232X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,6,26]],"date-time":"2023-06-26T00:07:55Z","timestamp":1687738075000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S152166161200232X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,12]]},"references-count":23,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["S152166161200232X"],"URL":"https:\/\/doi.org\/10.1016\/j.clim.2012.09.007","relation":{},"ISSN":["1521-6616"],"issn-type":[{"value":"1521-6616","type":"print"}],"subject":[],"published":{"date-parts":[[2012,12]]}}}